StockTipsArenaBeta

BUY Piramal Pharma Limited — IDBI Capital

BUYPiramal Pharma Limited
Piramal Pharma share price target & all analyst calls

byIDBI CapitalHorizon: NA (inferred 1–3 months)3 Jul 2026via IDBI Capital Research Calls Telegram

Entry₹176.6Stated
Target₹196
Total upside +10.99% (call closed)
Stop loss₹168.2-4.76% risk
Exit₹168.28 Jul 2026, 12:07 pm
Stop-loss hit-4.76%
Follow IDBI Capital for new calls(32% target hit, 187 closed calls)Get alertsWatch PPLPHARMA for new buy/sell callsGet alertsSee 2 active Short-term calls on PPLPHARMASee 43 active Short-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 22 Oct, 4:59 pm IST
2 supporting0 opposing
Supports the BUY call (2)

4 advisors have active long-term BUY calls on this stock, with 2 issued in the last 14 days

Advisor consensus · adjacent horizon·3 Jul · 4d ago

1 other SEBI-registered advisor has an active short-term BUY call on this stock

Advisor consensus · same horizon·27 May · 1mo ago

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Piramal Pharma

All analyst calls on Piramal Pharma

More from IDBI Capital

Every call and its outcome